Predicting Oxycodone Dose From Oral Fluid Drug Levels
NCT01928303 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2014-09-15
Summary
This study will develop and test an algorithm that will estimate drug dosage from drug levels measured in oral fluid (saliva). Traditionally, urine has been used as the principle medium to monitor drug compliance in patients receiving opioids for chronic pain as well as those being treated for substance abuse. Recently, the use of saliva as an alternative to urine drug testing has been gaining in popularity. Oral fluid has several advantages over urine as a medium for drug screening. In this study, oral fluid, urine and blood specimens will be collected from volunteer patient donors with chronic pain taking opioid medications. Samples from the anonymous donor will be analyzed for opiate class drugs, using New York State Department of Health approved and validated laboratory methods. Analytical results and other information collected will assist in evaluating the use of oral fluid as a specimen to detect opiate drug levels. The measurement of drug concentrations in blood and oral fluid simultaneously will allow for the determination of the amount of oral fluid that will be needed for successful drug testing. It is proposed that by measuring oral fluid drug levels an estimate of the amount of drug taken will be possible.
Conditions
Sponsors & Collaborators
-
Weill Medical College of Cornell University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 72 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2014-08-31
- Completion
- 2014-08-31
Countries
- United States
Study Locations
More Related Trials
-
Oxycodone User Registry (OUR)
NCT00978328 ·Status: COMPLETED
-
Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool
NCT05706311 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
User Acceptability of a Device-Based Opioid Overdose Intervention
NCT04530591 ·Status: COMPLETED
-
Opioid Physiology Project
NCT03462797 ·Status: COMPLETED
-
The Potential of Oxytocin to Reduce Opioid Abuse Liability and Pain Among Older Adults
NCT05761860 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Evaluation of a Computerized Opioid Overdose Prevention Program
NCT02040077 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability and Pharmacokinetics of NYX-783 and Oxycodone DDI Study
NCT05447286 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1
NCT00000320 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical Study
NCT02692157 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy
NCT03337009 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Buprenorphine's Dose Response Curve
NCT00460239 ·Status: COMPLETED ·Phase: PHASE2
-
Examining the Role of the Orexin System in Sleep and Stress in Persons With Opioid Use Disorder
NCT04287062 ·Status: COMPLETED ·Phase: PHASE2
-
Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
NCT00000302 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Liquid vs. Tablet Buprenorphine - 6
NCT00000341 ·Status: COMPLETED ·Phase: PHASE2
-
Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose
NCT06316830 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Effects of Ethanol on Oxycodone Pharmacokinetics in Healthy Volunteers
NCT02165930 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain
NCT02276989 ·Status: WITHDRAWN ·Phase: PHASE2
-
Sublingual Buprenorphine for Chronic Pain
NCT00612287 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.
NCT03389750 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse
NCT00699010 ·Status: COMPLETED ·Phase: PHASE2
-
Opioids in Chronic Kidney Disease Patients Undergoing Hemodialysis
NCT02452437 ·Status: UNKNOWN ·Phase: PHASE4
-
Long-Term Opioid Therapy in Chronic Non-Cancer Pain: Risks and Benefits
NCT06063902 ·Status: ENROLLING_BY_INVITATION
-
Predictive Markers of the Effects of Opioid Therapy
NCT02308306 ·Status: COMPLETED
-
Biomarkers of Injectable Extended Release Naltrexone Treatment
NCT02324725 ·Status: COMPLETED ·Phase: PHASE4
-
Abuse Liability of Suboxone Versus Subutex
NCT00710385 ·Status: COMPLETED ·Phase: PHASE3